U.S. Machinery Stock News

Thinking about whether WNS (Holdings) deserves a spot in your portfolio right now? You are not alone. The stock has been on quite a journey lately, catching the eyes of both seasoned investors and curious newcomers. After all, with a remarkable year-to-date gain of 61.3% and a one-year return of 56.0%, it is hard not to notice. While the past three years have seen some bumps, including a -6.4% dip, the company’s strong rebound over the past year suggests a shift in market sentiment, possibly...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Thinking about what to do with Phillips Edison stock? You're not alone. With market moods shifting and real estate stocks getting a fresh look, it’s natural to wonder if now is the time to hold, buy more, or head for the exit. Over the past year, Phillips Edison has seen some ups and downs, including a recent 1-week slip of -1.4%, a pullback of -6.6% in the last month, and a year-to-date return of -8.7%. Looking over a longer period, the stock is actually up 30.4% over the past three years...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Cinemark Holdings, Inc. ( NYSE:CNK ), might not be a large cap stock, but it saw a double-digit share price rise of...

Key Insights Significantly high institutional ownership implies Universal Insurance Holdings' stock price is sensitive...

The JELD-WEN Holding, Inc. ( NYSE:JELD ) share price has softened a substantial 28% over the previous 30 days, handing...

As the U.S. market experiences mixed results with major indices like the S&P 500 and Dow Jones Industrial Average setting new records, small-cap stocks continue to garner attention amid economic uncertainties such as the ongoing government shutdown. In this dynamic environment, identifying promising small-cap opportunities often involves looking at companies with strong fundamentals and notable insider activity, which can signal confidence in their potential despite broader market challenges.

As the U.S. stock market navigates through a period of mixed performance with major indices setting new records despite challenges like a government shutdown, investors are keenly observing opportunities that may be undervalued amidst these fluctuations. In such an environment, identifying stocks that are trading at significant discounts can offer potential value, especially when considering broader economic factors and sector-specific developments.

In the current U.S. market landscape, major stock indexes have shown resilience with weekly gains despite mixed endings and external pressures such as a government shutdown affecting economic data releases. Amidst this backdrop, growth companies with high insider ownership can offer unique insights into potential value, as insiders often have intimate knowledge of their company's prospects and challenges.

As of October 2025, the U.S. stock market has shown resilience with major indices like the Dow Jones Industrial Average and S&P 500 setting new records, despite mixed performances and economic uncertainties stemming from a government shutdown. In this dynamic environment, identifying promising small-cap stocks can be particularly rewarding as these companies often offer unique growth opportunities that larger firms may not provide.

Key Insights Simpson Manufacturing's estimated fair value is US$273 based on 2 Stage Free Cash Flow to Equity Simpson...

For many, the main point of investing in the stock market is to achieve spectacular returns. While not every stock...

DXP Enterprises, Inc. ( NASDAQ:DXPE ), is not the largest company out there, but it saw a significant share price rise...

RPM International Inc.'s ( NYSE:RPM ) periodic dividend will be increasing on the 31st of October to $0.54, with...

We wouldn't blame IDT Corporation ( NYSE:IDT ) shareholders if they were a little worried about the fact that Abilio...

Willdan Group (NASDAQ:WLDN) has had a great run on the share market with its stock up by a significant 27% over the...

Capri Holdings Limited ( NYSE:CPRI ) shareholders should be happy to see the share price up 14% in the last quarter...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...

With a price-to-earnings (or "P/E") ratio of 54.9x Materialise NV ( NASDAQ:MTLS ) may be sending very bearish signals...

Bakkt Holdings recently completed the sale of its loyalty business and appointed fintech veteran Mike Alfred to its board, marking a shift to a focused digital asset infrastructure platform. This transformation is underscored by renewed emphasis on Bitcoin, tokenized payments, and zero debt, signaling a significant realignment toward crypto and digital finance services. We'll explore how the company’s sharpened focus on digital assets and new leadership shapes Bakkt Holdings' investment...

Alto Neuroscience just received Fast Track designation from the FDA for ALTO-101, a new drug candidate aimed at treating cognitive impairment related to schizophrenia. This move could accelerate ALTO-101’s development and review process. See our latest analysis for Alto Neuroscience. The FDA’s support for ALTO-101 sparked fresh interest in Alto Neuroscience. However, despite the headline, its 1-year total shareholder return remains nearly flat while recent share price momentum has been...

Thinking about what to do with Informatica stock? You are not alone. Recent movement in the shares has caught a lot of attention, and there is no shortage of opinions out there. Right now, the stock is hovering near $24.92, and you might notice the numbers are a bit of a mixed bag. Over the past week and month, Informatica has inched up by 0.4% and 0.6% respectively, but if you look at the year-to-date performance, it is down 2.1%. The past year also shows a slight dip, with shares falling...

ClearPoint Neuro recently announced the appointment of Dr. Paul Larson as Chief Medical Officer, the unveiling of its proprietary Robotic Neuro-Navigation System for minimally invasive cranial procedures, and new insider buying from directors. The Robotic Neuro-Navigation System aims to provide greater consistency for cell and gene therapy delivery, and ClearPoint's drug delivery technology was spotlighted in strong Huntington's disease trial results from a biopharma collaborator. Let's...